Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7104230

COc1ccc(CCNC(=O)C(N)C(=O)NCCc2ccc(OC)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.56
TAAR1 Q96RJ0 2/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 2/20 0.51
GLA P06280 1/20 0.51
FPR2 P25090 1/20 0.51
NPC1 O15118 1/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 1/20 0.50
PLAAT3 P53816 1/20 0.50
PLAAT5 Q96KN8 1/20 0.50
PLAAT2 Q9NWW9 1/20 0.50
PLAAT4 Q9UL19 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7943506 0.88 SMN1; SMN2 (0.51) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
Trifluoroacetic Acid SCHEMBL7103734 0.84 MLYCD (0.54) KMT2ANPC1RAB9APLAAT3PLAAT5
Trifluoroacetic Acid SCHEMBL5072989 0.81 SMN1; SMN2 (0.56) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
SCHEMBL13073347 0.80 KMT2A (0.63) SMN1; SMN2TAAR1ALDH1A1KMT2AFPR2
SCHEMBL140038 0.79 SMN1; SMN2 (0.67) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
Trifluoroacetic Acid SCHEMBL3665235 0.79 SMN1; SMN2 (0.52) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
SCHEMBL11713117 0.79 SMN1; SMN2 (0.58) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
SCHEMBL6977801 0.79 SMN1; SMN2 (0.58) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
SCHEMBL7943508 0.79 SMN1; SMN2 (0.49) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA
SCHEMBL7904484 0.78 SMN1; SMN2 (0.69) SMN1; SMN2TAAR1ALDH1A1KMT2AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140818-B1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2003-09-10 EP disclosed
US-6329550-B1 FOR THERAPY OF EMPHYSEMA, OSTEOPOROSIS, RHEUMATOID ARTHRITIS AND NEOPLASTIC DISEASES AVENTIS PHARMACEUTICALS INC. 2001-12-11 US disclosed